{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:49:08Z","timestamp":1791676148775,"version":"4.3.4"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":282,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/21955-3"],"award-info":[{"award-number":["2024\/21955-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) is a heterogeneous neurodegenerative disorder characterized by complex molecular alterations and diverse cognitive, behavioral, and neuropsychiatric manifestations. Although transcriptomic studies have identified several pathways associated with AD, the integration of molecular signatures with disease-related phenotype annotations and pathological aging remains incompletely understood. Therefore, this study aimed to integrate transcriptomic profiling, protein\u2013protein interaction (PPI) network analysis, pathological aging assessment, and curated clinical phenotype annotations to prioritize candidate molecular signatures associated with AD. Differential expression analyses and network-based approaches were applied to publicly available transcriptomic datasets derived from distinct brain regions. Candidate genes and pathways were prioritized through interactome reconstruction, functional enrichment analyses, cluster-based analyses, and independent validation in an external dataset. In addition, transcriptomic signatures were integrated with curated clinical phenotype annotations using a knowledge-based gene overlap strategy. The analysis identified molecular signatures associated with neuroinflammatory signaling, synaptic dysfunction, endocytosis, and pathological aging. Pathways related to MAPK, PI3K\/Akt, NF-\u03baB, and TGF-\u03b21 signaling emerged as candidate dysregulated pathways in AD. Comparative analyses of physiological aging and the AD aging comparison enabled the prioritization of candidate genes potentially more closely associated with the AD condition than with aging alone, including\n                    <jats:italic>FOS<\/jats:italic>\n                    and\n                    <jats:italic>TAB2<\/jats:italic>\n                    . Independent validation reinforced the reproducibility of several prioritized genes, including\n                    <jats:italic>GFAP<\/jats:italic>\n                    ,\n                    <jats:italic>CXCR4<\/jats:italic>\n                    ,\n                    <jats:italic>CCL2<\/jats:italic>\n                    ,\n                    <jats:italic>HSPA1A<\/jats:italic>\n                    ,\n                    <jats:italic>FCGR2A<\/jats:italic>\n                    ,\n                    <jats:italic>TLR2<\/jats:italic>\n                    ,\n                    <jats:italic>CD44<\/jats:italic>\n                    ,\n                    <jats:italic>TLR4<\/jats:italic>\n                    ,\n                    <jats:italic>FOS<\/jats:italic>\n                    ,\n                    <jats:italic>TAB2<\/jats:italic>\n                    ,\n                    <jats:italic>CDC42<\/jats:italic>\n                    , and\n                    <jats:italic>SH3GL2<\/jats:italic>\n                    . Integration with curated clinical phenotype annotations suggested partially overlapping molecular signatures across neuropsychiatric and cognitive phenotype annotations in AD. Together, these findings demonstrate the utility of integrative bioinformatics approaches for prioritizing candidate genes, pathways, and molecular signatures associated with AD. This systems-level framework may contribute to future mechanistic studies aimed at understanding the molecular heterogeneity of AD and its associated phenotypic complexity.\n                  <\/jats:p>","DOI":"10.1007\/s12035-026-06258-0","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:27:12Z","timestamp":1791664032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative Transcriptomic and Interactome Analyses Prioritize Candidate Genes for Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Giovanni Monteiro","family":"Maglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolly Clemente","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Miguel","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"6258_CR1","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/CSHPERSPECT.A006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6258_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/CSHPERSPECT.A006239","volume":"2","author":"R Mayeux","year":"2012","unstructured":"Mayeux R, Stern Y (2012) Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2:a006239. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A006239","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6258_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/HJAHN","volume":"15","author":"H Jahn","year":"2013","unstructured":"Jahn H (2013) Memory loss in Alzheimer\u2019s disease. Dialogues Clin Neurosci 15:445\u2013454. https:\/\/doi.org\/10.31887\/DCNS.2013.15.4\/HJAHN","journal-title":"Dialogues Clin Neurosci"},{"key":"6258_CR4","doi-asserted-by":"publisher","first-page":"1263771","DOI":"10.3389\/FNINS.2023.1263771\/FULL","volume":"17","author":"A Pless","year":"2023","unstructured":"Pless A, Ware D, Saggu S et al (2023) Understanding neuropsychiatric symptoms in Alzheimer\u2019s disease: challenges and advances in diagnosis and treatment. Front Neurosci 17:1263771. https:\/\/doi.org\/10.3389\/FNINS.2023.1263771\/FULL","journal-title":"Front Neurosci"},{"key":"6258_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.2174\/1567205012666150701103107\/CITE\/REFWORKS","volume":"12","author":"J Raskin","year":"2015","unstructured":"Raskin J, Cummings J, Hardy J et al (2015) Neurobiology of Alzheimer\u2019s disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Curr Alzheimer Res 12:712\u2013722. https:\/\/doi.org\/10.2174\/1567205012666150701103107\/CITE\/REFWORKS","journal-title":"Curr Alzheimer Res"},{"key":"6258_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/J.JAGP.2018.10.008","volume":"27","author":"R Yu","year":"2019","unstructured":"Yu R, Topiwala A, Jacoby R, Fazel S (2019) Aggressive behaviors in Alzheimer disease and mild cognitive impairment: systematic review and meta-analysis. Am J Geriatr Psychiatry 27:290\u2013300. https:\/\/doi.org\/10.1016\/J.JAGP.2018.10.008","journal-title":"Am J Geriatr Psychiatry"},{"key":"6258_CR7","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1055\/S-0043-1777774\/ID\/JR230228-36\/BIB","volume":"81","author":"AL Teixeira","year":"2023","unstructured":"Teixeira AL, Rocha NP, Gatchel J (2023) Behavioral or neuropsychiatric symptoms of Alzheimer\u2019s disease: from psychopathology to pharmacological management. Arq Neuropsiquiatr 81:1152\u20131162. https:\/\/doi.org\/10.1055\/S-0043-1777774\/ID\/JR230228-36\/BIB","journal-title":"Arq Neuropsiquiatr"},{"key":"6258_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11920-015-0640-7\/METRICS","volume":"18","author":"AM Koenig","year":"2016","unstructured":"Koenig AM, Arnold SE, Streim JE (2016) Agitation and irritability in Alzheimer\u2019s disease: evidenced-based treatments and the black-box warning. Curr Psychiatry Rep 18:1\u201310. https:\/\/doi.org\/10.1007\/S11920-015-0640-7\/METRICS","journal-title":"Curr Psychiatry Rep"},{"key":"6258_CR9","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2174\/1567205013666160502123607\/CITE\/REFWORKS","volume":"13","author":"DD Van","year":"2016","unstructured":"Van DD, Vermeiren Y, Dekker AD et al (2016) Neuropsychiatric disturbances in Alzheimer\u2019s disease: what have we learned from neuropathological studies? Curr Alzheimer Res 13:1145\u20131164. https:\/\/doi.org\/10.2174\/1567205013666160502123607\/CITE\/REFWORKS","journal-title":"Curr Alzheimer Res"},{"key":"6258_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/J.JAGP.2013.06.005","volume":"22","author":"DL Sultzer","year":"2014","unstructured":"Sultzer DL, Leskin LP, Melrose RJ et al (2014) Neurobiology of delusions, memory, and insight in Alzheimer disease. Am J Geriatr Psychiatry 22:1346\u20131355. https:\/\/doi.org\/10.1016\/J.JAGP.2013.06.005","journal-title":"Am J Geriatr Psychiatry"},{"key":"6258_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/J.1755-5949.2011.00251.X","volume":"18","author":"D Friedman","year":"2012","unstructured":"Friedman D, Honig LS, Scarmeas N (2012) Seizures and epilepsy in Alzheimer\u2019s disease. CNS Neurosci Ther 18:285\u2013294. https:\/\/doi.org\/10.1111\/J.1755-5949.2011.00251.X","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"6258_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/S13195-023-01279-6","volume":"15","author":"GJ Goodwin","year":"2023","unstructured":"Goodwin GJ, Moeller S, Nguyen A et al (2023) Network analysis of neuropsychiatric symptoms in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 15(1):135. https:\/\/doi.org\/10.1186\/S13195-023-01279-6","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"6258_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2016.00073\/BIBTEX","volume":"3","author":"M Canevelli","year":"2016","unstructured":"Canevelli M, Valletta M, Trebbastoni A et al (2016) Sundowning in dementia: Clinical relevance, pathophysiological determinants, and therapeutic approaches. Front Med (Lausanne) 3:237904. https:\/\/doi.org\/10.3389\/FMED.2016.00073\/BIBTEX","journal-title":"Front Med (Lausanne)"},{"key":"6258_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-230380;PAGE:STRING:ARTICLE\/CHAPTER","volume":"96","author":"C Polin","year":"2023","unstructured":"Polin C, Gell\u00e9 T, Auditeau E et al (2023) Repetitive behaviors in Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimer\u2019s Dis 96:483\u2013497. https:\/\/doi.org\/10.3233\/JAD-230380;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"J Alzheimer\u2019s Dis"},{"key":"6258_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1590\/1980-5764-DN-2021-0029","volume":"16","author":"KF Lopes","year":"2022","unstructured":"Lopes KF, Bahia VS, Natividade JC et al (2022) Changes in personality traits in patients with Alzheimer\u2019s disease. Dement Neuropsychol 16:187\u2013193. https:\/\/doi.org\/10.1590\/1980-5764-DN-2021-0029","journal-title":"Dement Neuropsychol"},{"key":"6258_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0133666","volume":"10","author":"K Kai","year":"2015","unstructured":"Kai K, Hashimoto M, Amano K et al (2015) Relationship between eating disturbance and dementia severity in patients with Alzheimer\u2019s disease. PLoS ONE 10:e0133666. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0133666","journal-title":"PLoS ONE"},{"key":"6258_CR17","unstructured":"Thomas T, Ritter A (2022) Wandering & sundowning in dementia. Practical Neurology. https:\/\/practicalneurology.com\/diseases-diagnoses\/alzheimer-disease-dementias\/wandering-sundowning-in-dementia\/31912\/. Accessed 3 Mar 2026"},{"key":"6258_CR18","doi-asserted-by":"publisher","unstructured":"Kakkar A, Singh H, Anand A et al (2025) A comprehensive review of genetic risk factors for Alzheimer\u2019s disease development. Curr Gene Ther 25. https:\/\/doi.org\/10.2174\/0115665232397101250916050247","DOI":"10.2174\/0115665232397101250916050247"},{"key":"6258_CR19","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.3390\/NU14193907\/S1","volume":"14","author":"A Mulugeta","year":"2022","unstructured":"Mulugeta A, Navale SS, Lumsden AL et al (2022) Healthy lifestyle, genetic risk and brain health: a gene-environment interaction study in the UK Biobank. Nutrients 14:3907. https:\/\/doi.org\/10.3390\/NU14193907\/S1","journal-title":"Nutrients"},{"issue":"1","key":"6258_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/S13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A (2017) Multi-omics approaches to disease. Genome Biol 18(1):18\u201315. https:\/\/doi.org\/10.1186\/S13059-017-1215-1","journal-title":"Genome Biol"},{"issue":"1","key":"6258_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/S40478-018-0524-2","volume":"6","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Ma C, Gearing M et al (2018) Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer\u2019s disease. Acta Neuropathol Commun 6(1):6\u201319. https:\/\/doi.org\/10.1186\/S40478-018-0524-2","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"6258_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-89334-0","volume":"15","author":"LM de Carvalho","year":"2025","unstructured":"de Carvalho LM, Carvalho VMA, Camargo AP, Papes F (2025) Gene network analysis identifies dysregulated pathways in an autism spectrum disorder caused by mutations in transcription factor 4. Sci Rep 15(1):4993. https:\/\/doi.org\/10.1038\/s41598-025-89334-0","journal-title":"Sci Rep"},{"key":"6258_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biology13110848","volume":"13","author":"PHG Sanches","year":"2024","unstructured":"Sanches PHG, de Melo NC, Porcari AM, de Carvalho LM (2024) Integrating molecular perspectives: strategies for comprehensive multi-omics integrative data analysis and machine learning applications in transcriptomics, proteomics, and metabolomics. Biology (Basel) 13:848. https:\/\/doi.org\/10.3390\/biology13110848","journal-title":"Biology (Basel)"},{"key":"6258_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/J.ARR.2021.101346","volume":"69","author":"H Hampel","year":"2021","unstructured":"Hampel H, Nistic\u00f2 R, Seyfried NT et al (2021) Omics sciences for systems biology in Alzheimer\u2019s disease: state-of-the-art of the evidence. Ageing Res Rev 69:101346. https:\/\/doi.org\/10.1016\/J.ARR.2021.101346","journal-title":"Ageing Res Rev"},{"issue":"1","key":"6258_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/S13024-020-00405-4","volume":"15","author":"CG Mangleburg","year":"2020","unstructured":"Mangleburg CG, Wu T, Yalamanchili HK et al (2020) Integrated analysis of the aging brain transcriptome and proteome in tauopathy. Mol Neurodegener 15(1):56. https:\/\/doi.org\/10.1186\/S13024-020-00405-4","journal-title":"Mol Neurodegener"},{"key":"6258_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.6026\/973206300200140","volume":"20","author":"A Grewal","year":"2024","unstructured":"Grewal A, Sheokand D, Chauhan R et al (2024) Insights into amyloid precursor protein target through PPI network analysis. Bioinformation 20:140. https:\/\/doi.org\/10.6026\/973206300200140","journal-title":"Bioinformation"},{"key":"6258_CR27","doi-asserted-by":"publisher","unstructured":"Karbalaei R, Allahyari M, Rezaei-Tavirani M et al (2018) Protein-protein interaction analysis of Alzheimer`s disease and NAFLD based on systems biology methods unhide common ancestor pathways. Gastroenterol Hepatol Bed Bench 11:27. https:\/\/doi.org\/10.22037\/ghfbb.v0i0.1327","DOI":"10.22037\/ghfbb.v0i0.1327"},{"key":"6258_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/BS.APCSB.2023.11.005","volume":"139","author":"V Kumar","year":"2024","unstructured":"Kumar V, Roy K (2024) Protein-protein interaction network analysis for the identification of novel multi-target inhibitors and target miRNAs against Alzheimer\u2019s disease. Adv Protein Chem Struct Biol 139:405\u2013467. https:\/\/doi.org\/10.1016\/BS.APCSB.2023.11.005","journal-title":"Adv Protein Chem Struct Biol"},{"key":"6258_CR29","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3233\/JAD-181085","volume":"68","author":"H Patel","year":"2019","unstructured":"Patel H, Dobson RJB, Newhouse SJ (2019) A meta-analysis of Alzheimer\u2019s disease brain transcriptomic data. J Alzheimers Dis 68:1635\u20131656. https:\/\/doi.org\/10.3233\/JAD-181085","journal-title":"J Alzheimers Dis"},{"key":"6258_CR30","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/HMG\/DDAA182","volume":"29","author":"S Morabito","year":"2020","unstructured":"Morabito S, Miyoshi E, Michael N, Swarup V (2020) Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer\u2019s disease. Hum Mol Genet 29:2899\u20132919. https:\/\/doi.org\/10.1093\/HMG\/DDAA182","journal-title":"Hum Mol Genet"},{"key":"6258_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/SCIADV.ABB5398","author":"RA Neff","year":"2021","unstructured":"Neff RA, Wang M, Vatansever S et al (2021) Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv. https:\/\/doi.org\/10.1126\/SCIADV.ABB5398","journal-title":"Sci Adv"},{"issue":"1","key":"6258_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41398-024-02878-z","volume":"14","author":"DW Fisher","year":"2024","unstructured":"Fisher DW, Dunn JT, Keszycki R et al (2024) Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer\u2019s disease. Transl Psychiatry 14(1):178. https:\/\/doi.org\/10.1038\/s41398-024-02878-z","journal-title":"Transl Psychiatry"},{"key":"6258_CR33","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1007\/S12035-023-03690-4","volume":"61","author":"B Ceylan","year":"2024","unstructured":"Ceylan B, D\u00fcz E, \u00c7akir T (2024) Personalized protein-protein interaction networks towards unraveling the molecular mechanisms of Alzheimer\u2019s disease. Mol Neurobiol 61:2120\u20132135. https:\/\/doi.org\/10.1007\/S12035-023-03690-4","journal-title":"Mol Neurobiol"},{"issue":"1","key":"6258_CR34","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1038\/s41598-023-30892-6","volume":"13","author":"P Kodam","year":"2023","unstructured":"Kodam P, Sai Swaroop R, Pradhan SS et al (2023) Integrated multi-omics analysis of Alzheimer\u2019s disease shows molecular signatures associated with disease progression and potential therapeutic targets. Sci Rep 13(1):3695. https:\/\/doi.org\/10.1038\/s41598-023-30892-6","journal-title":"Sci Rep"},{"key":"6258_CR35","doi-asserted-by":"publisher","first-page":"1358998","DOI":"10.3389\/FNINS.2024.1358998\/FULL","volume":"18","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Liu X, Zhang S et al (2024) A review and analysis of key biomarkers in Alzheimer\u2019s disease. Front Neurosci 18:1358998. https:\/\/doi.org\/10.3389\/FNINS.2024.1358998\/FULL","journal-title":"Front Neurosci"},{"key":"6258_CR36","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/NAR\/GKU1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S et al (2015) STRING v10: protein\u2013protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43:D447\u2013D452. https:\/\/doi.org\/10.1093\/NAR\/GKU1003","journal-title":"Nucleic Acids Res"},{"key":"6258_CR37","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/GR.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498. https:\/\/doi.org\/10.1101\/GR.1239303","journal-title":"Genome Res"},{"key":"6258_CR38","doi-asserted-by":"publisher","unstructured":"Harris MA, Clark J, Ireland A et al (2004) The Gene Oncology (GO) database and informatics resource. Nucleic Acids Res 32. https:\/\/doi.org\/10.1093\/nar\/gkh036","DOI":"10.1093\/nar\/gkh036"},{"key":"6258_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28:27\u201330","journal-title":"Nucleic Acids Res"},{"key":"6258_CR40","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J et al (2022) DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 50:W216\u2013W221. https:\/\/doi.org\/10.1093\/nar\/gkac194","journal-title":"Nucleic Acids Res"},{"key":"6258_CR41","doi-asserted-by":"publisher","unstructured":"Reichenbach N, Delekate A, Plescher M et al (2019) Inhibition of Stat3\u2010mediated astrogliosis ameliorates pathology in an Alzheimer\u2019s disease model. EMBO Mol Med 11. https:\/\/doi.org\/10.15252\/EMMM.201809665;PAGEGROUP:STRING:PUBLICATION","DOI":"10.15252\/EMMM.201809665;PAGEGROUP:STRING:PUBLICATION"},{"key":"6258_CR42","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/J.DRUDIS.2014.06.029","volume":"19","author":"X Cheng","year":"2014","unstructured":"Cheng X, Shen Y, Li R (2014) Targeting TNF: a therapeutic strategy for Alzheimer\u2019s disease. Drug Discov Today 19:1822\u20131827. https:\/\/doi.org\/10.1016\/J.DRUDIS.2014.06.029","journal-title":"Drug Discov Today"},{"key":"6258_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/IJNP\/PYAE038","volume":"28","author":"D Jin","year":"2024","unstructured":"Jin D, Zhang M, Shi L, Liu H (2024) Investigating the impact of IL-6 and CXCL8 on neurodegeneration and cognitive decline in Alzheimer disease. Int J Neuropsychopharmacol 28:38. https:\/\/doi.org\/10.1093\/IJNP\/PYAE038","journal-title":"Int J Neuropsychopharmacol"},{"key":"6258_CR44","doi-asserted-by":"publisher","unstructured":"Mastroeni D, Chan CK, Morshed N et al (2024) Upregulation of the proto-oncogene Src kinase in Alzheimer\u2019s disease: from molecular interactions to therapeutic potential. bioRxiv 2024.02.07.579336. https:\/\/doi.org\/10.1101\/2024.02.07.579336","DOI":"10.1101\/2024.02.07.579336"},{"key":"6258_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4308\/HJB.31.1.145-152","volume":"31","author":"L Rosmanah","year":"2024","unstructured":"Rosmanah L, Saepuloh U, Mariya SS et al (2024) Expression of APP, CDK5, and AKT1 gene related to Alzheimer disease in brain of long-tailed macaques. Hayati J Biosci 31:145\u2013152. https:\/\/doi.org\/10.4308\/HJB.31.1.145-152","journal-title":"Hayati J Biosci"},{"key":"6258_CR46","doi-asserted-by":"publisher","first-page":"1025066","DOI":"10.3389\/FNMOL.2022.1025066\/BIBTEX","volume":"15","author":"S Pang","year":"2023","unstructured":"Pang S, Li S, Cheng H et al (2023) Discovery of an evodiamine derivative for PI3K\/AKT\/GSK3\u03b2 pathway activation and AD pathology improvement in mouse models. Front Mol Neurosci 15:1025066. https:\/\/doi.org\/10.3389\/FNMOL.2022.1025066\/BIBTEX","journal-title":"Front Mol Neurosci"},{"key":"6258_CR47","doi-asserted-by":"publisher","first-page":"1143328","DOI":"10.3389\/FPSYT.2023.1143328\/BIBTEX","volume":"14","author":"W Zhuang","year":"2023","unstructured":"Zhuang W, Ye T, Wang W et al (2023) CTNNB1 in neurodevelopmental disorders. Front Psychiatry 14:1143328. https:\/\/doi.org\/10.3389\/FPSYT.2023.1143328\/BIBTEX","journal-title":"Front Psychiatry"},{"key":"6258_CR48","doi-asserted-by":"publisher","first-page":"1029473","DOI":"10.3389\/FNINS.2022.1029473\/BIBTEX","volume":"16","author":"P Wolfrum","year":"2022","unstructured":"Wolfrum P, Fietz A, Schnichels S, Hurst J (2022) The function of p53 and its role in Alzheimer\u2019s and Parkinson\u2019s disease compared to age-related macular degeneration. Front Neurosci 16:1029473. https:\/\/doi.org\/10.3389\/FNINS.2022.1029473\/BIBTEX","journal-title":"Front Neurosci"},{"key":"6258_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/BPA.13235;PAGEGROUP:STRING:PUBLICATION","volume":"34","author":"V Astillero-Lopez","year":"2024","unstructured":"Astillero-Lopez V, Villar-Conde S, Gonzalez-Rodriguez M et al (2024) Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer\u2019s disease: potential role in synaptic homeostasis and A\u03b2 pathology through microglial and astroglial cells. Brain Pathol 34:e13235. https:\/\/doi.org\/10.1111\/BPA.13235;PAGEGROUP:STRING:PUBLICATION","journal-title":"Brain Pathol"},{"key":"6258_CR50","doi-asserted-by":"publisher","first-page":"1238639","DOI":"10.3389\/FPHAR.2023.1238639\/FULL","volume":"14","author":"HJ Choi","year":"2023","unstructured":"Choi HJ, Jeong YJ, Kim J, Hoe HS (2023) EGFR is a potential dual molecular target for cancer and Alzheimer\u2019s disease. Front Pharmacol 14:1238639. https:\/\/doi.org\/10.3389\/FPHAR.2023.1238639\/FULL","journal-title":"Front Pharmacol"},{"key":"6258_CR51","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/S12192-021-01231-3","volume":"26","author":"E Razani","year":"2021","unstructured":"Razani E, Pourbagheri-Sigaroodi A, Safaroghli-Azar A et al (2021) The PI3K\/Akt signaling axis in Alzheimer\u2019s disease: a valuable target to stimulate or suppress? Cell Stress Chaperones 26:871\u2013887. https:\/\/doi.org\/10.1007\/S12192-021-01231-3","journal-title":"Cell Stress Chaperones"},{"key":"6258_CR52","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1007\/S12035-022-02909-0","volume":"59","author":"H Lin","year":"2022","unstructured":"Lin H, Dixon SG, Hu W et al (2022) P38 MAPK is a major regulator of amyloid beta-induced IL-6 expression in human microglia. Mol Neurobiol 59:5284\u20135298. https:\/\/doi.org\/10.1007\/S12035-022-02909-0","journal-title":"Mol Neurobiol"},{"key":"6258_CR53","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/JNR.24829","volume":"99","author":"MJ Chen","year":"2021","unstructured":"Chen MJ, Ramesha S, Weinstock LD et al (2021) Extracellular signal-regulated kinase regulates microglial immune responses in Alzheimer\u2019s disease. J Neurosci Res 99:1704\u20131721. https:\/\/doi.org\/10.1002\/JNR.24829","journal-title":"J Neurosci Res"},{"key":"6258_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-023-02853-3\/TABLES\/1","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20:1\u201321. https:\/\/doi.org\/10.1186\/S12974-023-02853-3\/TABLES\/1","journal-title":"J Neuroinflammation"},{"key":"6258_CR55","doi-asserted-by":"publisher","unstructured":"Li X, Teng T, Yan W et al (2023) AKT and MAPK signaling pathways in hippocampus reveals the pathogenesis of depression in four stress-induced models. Transl Psychiatry 13. https:\/\/doi.org\/10.1038\/S41398-023-02486-3","DOI":"10.1038\/S41398-023-02486-3"},{"key":"6258_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM13030544","volume":"13","author":"J Amini","year":"2023","unstructured":"Amini J, Beyer C, Zendedel A, Sanadgol N (2023) MAPK is a mutual pathway targeted by anxiety-related miRNAs, and E2F5 is a putative target for anxiolytic miRNAs. Biomolecules 13:544. https:\/\/doi.org\/10.3390\/BIOM13030544","journal-title":"Biomolecules"},{"key":"6258_CR57","doi-asserted-by":"publisher","first-page":"1459025","DOI":"10.3389\/FNAGI.2024.1459025\/FULL","volume":"16","author":"J Pan","year":"2024","unstructured":"Pan J, Yao Q, Wang Y et al (2024) The role of PI3K signaling pathway in Alzheimer\u2019s disease. Front Aging Neurosci 16:1459025. https:\/\/doi.org\/10.3389\/FNAGI.2024.1459025\/FULL","journal-title":"Front Aging Neurosci"},{"key":"6258_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBAMCR.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D (2020) Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys Acta (BBA) Mol Cell Res 1867:118664. https:\/\/doi.org\/10.1016\/J.BBAMCR.2020.118664","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Res"},{"key":"6258_CR59","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/S41380-019-0458-5;TECHMETA","volume":"26","author":"ER Mahoney","year":"2021","unstructured":"Mahoney ER, Dumitrescu L, Moore AM et al (2021) Brain expression of the vascular endothelial growth factor gene family in cognitive aging and Alzheimer\u2019s disease. Mol Psychiatry 26:888\u2013896. https:\/\/doi.org\/10.1038\/S41380-019-0458-5;TECHMETA","journal-title":"Mol Psychiatry"},{"key":"6258_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2024.107300","volume":"206","author":"N Guo","year":"2024","unstructured":"Guo N, Wang X, Xu M et al (2024) PI3K\/AKT signaling pathway: molecular mechanisms and therapeutic potential in depression. Pharmacol Res 206:107300. https:\/\/doi.org\/10.1016\/J.PHRS.2024.107300","journal-title":"Pharmacol Res"},{"key":"6258_CR61","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4103\/2045-9912.385939","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, Lu D, Wang X et al (2024) The effects of nitric oxide in Alzheimer\u2019s disease. Med Gas Res 14:186\u2013191. https:\/\/doi.org\/10.4103\/2045-9912.385939","journal-title":"Med Gas Res"},{"key":"6258_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIOX12030753","volume":"12","author":"OM Iova","year":"2023","unstructured":"Iova OM, Marin GE, Lazar I et al (2023) Nitric oxide\/nitric oxide synthase system in the pathogenesis of neurodegenerative disorders\u2014an overview. Antioxidants (Basel) 12:753. https:\/\/doi.org\/10.3390\/ANTIOX12030753","journal-title":"Antioxidants (Basel)"},{"key":"6258_CR63","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3233\/JAD-142814","volume":"45","author":"JW Wright","year":"2015","unstructured":"Wright JW, Harding JW (2015) The brain hepatocyte growth factor\/c-Met receptor system: a new target for the treatment of Alzheimer\u2019s disease. J Alzheimers Dis 45:985\u20131000. https:\/\/doi.org\/10.3233\/JAD-142814","journal-title":"J Alzheimers Dis"},{"key":"6258_CR64","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/S12015-022-10335-X\/FIGURES\/8","volume":"18","author":"X Mi","year":"2022","unstructured":"Mi X, Jiao W, Yang Y et al (2022) HGF secreted by mesenchymal stromal cells promotes primordial follicle activation by increasing the activity of the PI3K-AKT signaling pathway. Stem Cell Rev Rep 18:1834\u20131850. https:\/\/doi.org\/10.1007\/S12015-022-10335-X\/FIGURES\/8","journal-title":"Stem Cell Rev Rep"},{"key":"6258_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2022.954266\/BIBTEX","volume":"14","author":"J Wei","year":"2022","unstructured":"Wei J, Ma X, Nehme A et al (2022) Reduced HGF\/MET signaling may contribute to the synaptic pathology in an Alzheimer\u2019s disease mouse model. Front Aging Neurosci 14:954266. https:\/\/doi.org\/10.3389\/FNAGI.2022.954266\/BIBTEX","journal-title":"Front Aging Neurosci"},{"key":"6258_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/GPS.4705;JOURNAL:JOURNAL:10991166;WGROUP:STRING:PUBLICATION","volume":"33","author":"NG Regier","year":"2018","unstructured":"Regier NG, Gitlin LN (2018) Dementia-related restlessness: relationship to characteristics of persons with dementia and family caregivers. Int J Geriatr Psychiatry 33:185\u2013192. https:\/\/doi.org\/10.1002\/GPS.4705;JOURNAL:JOURNAL:10991166;WGROUP:STRING:PUBLICATION","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"6258_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11011-025-01688-6","volume":"40","author":"J Lei","year":"2025","unstructured":"Lei J, Li J, Wu W et al (2025) Neuroprotective effects of Yangming-Kaixin-Yizhi formula in Alzheimer\u2019s disease: dual regulation of PI3K\/Akt and p38 MAPK signaling via network pharmacology and experimental approaches. Metab Brain Dis 40(7):1\u201316. https:\/\/doi.org\/10.1007\/S11011-025-01688-6","journal-title":"Metab Brain Dis"},{"key":"6258_CR68","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0092-8674(00)00038-6","volume":"102","author":"WS Garrett","year":"2000","unstructured":"Garrett WS, Chen LM, Kroschewski R et al (2000) Developmental control of endocytosis in dendritic cells by Cdc42. Cell 102:325\u2013334. https:\/\/doi.org\/10.1016\/S0092-8674(00)00038-6","journal-title":"Cell"},{"key":"6258_CR69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0166-2236(98)01264-8","volume":"21","author":"P Wigge","year":"1998","unstructured":"Wigge P, McMahon HT (1998) The amphiphysin family of proteins and their role in endocytosis at the synapse. Trends Neurosci 21:339\u2013344. https:\/\/doi.org\/10.1016\/S0166-2236(98)01264-8","journal-title":"Trends Neurosci"},{"key":"6258_CR70","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1593\/NEO.121956","volume":"15","author":"S Majumdar","year":"2013","unstructured":"Majumdar S, Gong EM, Vizio DD et al (2013) Loss of Sh3gl2\/endophilin a1 is a common event in urothelial carcinoma that promotes malignant behavior. Neoplasia N Y 15:749\u2013IN16. https:\/\/doi.org\/10.1593\/NEO.121956","journal-title":"Neoplasia N Y"},{"key":"6258_CR71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/S11357-023-00923-1\/FIGURES\/4","volume":"46","author":"\u0141 Zadka","year":"2024","unstructured":"Zadka \u0141, Sochocka M, Hachiya N et al (2024) Endocytosis and Alzheimer\u2019s disease. Geroscience 46:71\u201385. https:\/\/doi.org\/10.1007\/S11357-023-00923-1\/FIGURES\/4","journal-title":"Geroscience"},{"key":"6258_CR72","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1083\/JCB.201705017","volume":"216","author":"SL Schmid","year":"2017","unstructured":"Schmid SL (2017) Reciprocal regulation of signaling and endocytosis: implications for the evolving cancer cell. J Cell Biol 216:2623\u20132632. https:\/\/doi.org\/10.1083\/JCB.201705017","journal-title":"J Cell Biol"},{"key":"6258_CR73","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/MT.2013.54","volume":"21","author":"A El-Sayed","year":"2013","unstructured":"El-Sayed A, Harashima H (2013) Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis. Mol Ther 21:1118\u20131130. https:\/\/doi.org\/10.1038\/MT.2013.54","journal-title":"Mol Ther"},{"key":"6258_CR74","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/J.CEB.2020.05.009","volume":"65","author":"M Shafaq-Zadah","year":"2020","unstructured":"Shafaq-Zadah M, Dransart E, Johannes L (2020) Clathrin-independent endocytosis, retrograde trafficking, and cell polarity. Curr Opin Cell Biol 65:112\u2013121. https:\/\/doi.org\/10.1016\/J.CEB.2020.05.009","journal-title":"Curr Opin Cell Biol"},{"key":"6258_CR75","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuron.2019.07.010","volume":"104","author":"D Kwart","year":"2019","unstructured":"Kwart D, Gregg A, Scheckel C et al (2019) A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP \u03b2-CTFs, not A\u03b2. Neuron 104:256\u2013270.e5. https:\/\/doi.org\/10.1016\/j.neuron.2019.07.010","journal-title":"Neuron"},{"key":"6258_CR76","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/NN.4025;TECHMETA","volume":"18","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Sagare AP, Ma Q et al (2015) Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance. Nat Neurosci 18:978\u2013987. https:\/\/doi.org\/10.1038\/NN.4025;TECHMETA","journal-title":"Nat Neurosci"},{"key":"6258_CR77","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/S00401-013-1111-Z\/METRICS","volume":"125","author":"K Ando","year":"2013","unstructured":"Ando K, Brion JP, Stygelbout V et al (2013) Clathrin adaptor CALM\/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer\u2019s brains. Acta Neuropathol 125:861\u2013878. https:\/\/doi.org\/10.1007\/S00401-013-1111-Z\/METRICS","journal-title":"Acta Neuropathol"},{"key":"6258_CR78","doi-asserted-by":"publisher","unstructured":"Zhang M, Lin Y, Wei H et al (2025) The membrane receptor CD44: roles in neurodegenerative diseases. Expert Opin Ther Targets 1\u201310. https:\/\/doi.org\/10.1080\/14728222.2025.2563243","DOI":"10.1080\/14728222.2025.2563243"},{"key":"6258_CR79","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1172\/JCI27341","volume":"116","author":"I Tesseur","year":"2006","unstructured":"Tesseur I, Zou K, Esposito L et al (2006) Deficiency in neuronal TGF-\u03b2 signaling promotes neurodegeneration and Alzheimer\u2019s pathology. J Clin Invest 116:3060\u20133069. https:\/\/doi.org\/10.1172\/JCI27341","journal-title":"J Clin Invest"},{"key":"6258_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-023-02751-8\/FIGURES\/6","volume":"20","author":"M Kapoor","year":"2023","unstructured":"Kapoor M, Chinnathambi S (2023) TGF-\u03b21 signalling in Alzheimer\u2019s pathology and cytoskeletal reorganization: a specialized Tau perspective. J Neuroinflammation 20:1\u201320. https:\/\/doi.org\/10.1186\/S12974-023-02751-8\/FIGURES\/6","journal-title":"J Neuroinflammation"},{"key":"6258_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25063090","volume":"25","author":"N Vidovic","year":"2024","unstructured":"Vidovic N, Spittau B (2024) Microglial transforming growth factor-\u03b2 signaling in Alzheimer\u2019s disease. Int J Mol Sci 25:3090. https:\/\/doi.org\/10.3390\/IJMS25063090","journal-title":"Int J Mol Sci"},{"key":"6258_CR82","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/S12031-018-1219-7\/METRICS","volume":"67","author":"Y Hu","year":"2019","unstructured":"Hu Y, Chen W, Wu L et al (2019) TGF-\u03b21 restores hippocampal synaptic plasticity and memory in Alzheimer model via the PI3K\/Akt\/Wnt\/\u03b2-catenin signaling pathway. J Mol Neurosci 67:142\u2013149. https:\/\/doi.org\/10.1007\/S12031-018-1219-7\/METRICS","journal-title":"J Mol Neurosci"},{"key":"6258_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0116549","volume":"10","author":"JH Chen","year":"2015","unstructured":"Chen JH, Ke KF, Lu JH et al (2015) Protection of TGF-\u03b21 against neuroinflammation and neurodegeneration in A\u03b21\u201342-induced Alzheimer\u2019s disease model rats. PLoS ONE 10:e0116549. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0116549","journal-title":"PLoS ONE"},{"key":"6258_CR84","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1007\/S12035-024-03990-3\/FIGURES\/4","volume":"61","author":"S Petralla","year":"2024","unstructured":"Petralla S, Saveleva L, Kanninen KM et al (2024) Increased expression of transferrin receptor 1 in the brain cortex of 5xFAD mouse model of Alzheimer\u2019s disease is associated with activation of HIF-1 signaling pathway. Mol Neurobiol 61:6383\u20136394. https:\/\/doi.org\/10.1007\/S12035-024-03990-3\/FIGURES\/4","journal-title":"Mol Neurobiol"},{"key":"6258_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIOX13111378","volume":"13","author":"T-K; Lin","year":"2024","unstructured":"Lin T-K;, Huang C-R;, Lin K-J; et al (2024) Potential roles of hypoxia-inducible factor-1 in Alzheimer\u2019s disease: beneficial or detrimental? Antioxidants (Basel) 13:1378. https:\/\/doi.org\/10.3390\/ANTIOX13111378","journal-title":"Antioxidants (Basel)"},{"key":"6258_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25094581","volume":"25","author":"EV Mitroshina","year":"2024","unstructured":"Mitroshina EV, Vedunova MV (2024) The role of oxygen homeostasis and the HIF-1 factor in the development of neurodegeneration. Int J Mol Sci 25:4581. https:\/\/doi.org\/10.3390\/IJMS25094581","journal-title":"Int J Mol Sci"},{"key":"6258_CR87","doi-asserted-by":"publisher","first-page":"16140","DOI":"10.3390\/IJMS232416140\/S1","volume":"23","author":"L Lei","year":"2022","unstructured":"Lei L, Feng J, Wu G et al (2022) HIF-1\u03b1 causes LCMT1\/PP2A deficiency and mediates tau hyperphosphorylation and cognitive dysfunction during chronic hypoxia. Int J Mol Sci 23:16140. https:\/\/doi.org\/10.3390\/IJMS232416140\/S1","journal-title":"Int J Mol Sci"},{"key":"6258_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES11092587","volume":"11","author":"BS Sivamaruthi","year":"2023","unstructured":"Sivamaruthi BS, Raghani N, Chorawala M et al (2023) NF-\u03baB pathway and its inhibitors: a promising frontier in the management of Alzheimer\u2019s disease. Biomedicines Basel 11:2587. https:\/\/doi.org\/10.3390\/BIOMEDICINES11092587","journal-title":"Biomedicines Basel"},{"key":"6258_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S41983-023-00751-2\/FIGURES\/2","volume":"59","author":"J Limantoro","year":"2023","unstructured":"Limantoro J, de Liyis BG, Sutedja JC (2023) Akt signaling pathway: a potential therapy for Alzheimer\u2019s disease through glycogen synthase kinase 3 beta inhibition. Egypt J Neurol Psychiatry Neurosurg 59:1\u201314. https:\/\/doi.org\/10.1186\/S41983-023-00751-2\/FIGURES\/2","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"6258_CR90","doi-asserted-by":"publisher","first-page":"P1004","DOI":"10.1016\/J.JALZ.2019.06.3223","volume":"15","author":"KC Cheng","year":"2019","unstructured":"Cheng KC (2019) P3\u2013194: the distinct roles of EGFR downstream signaling in A\u03b2-induced pathologies. Alzheimers Dement 15:P1004\u2013P1004. https:\/\/doi.org\/10.1016\/J.JALZ.2019.06.3223","journal-title":"Alzheimers Dement"},{"key":"6258_CR91","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.3390\/IJMS23168972","volume":"23","author":"E Sun","year":"2022","unstructured":"Sun E, Motolani A, Campos L, Lu T (2022) \u00a0The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease. Int J Mol Sci 23:8972. https:\/\/doi.org\/10.3390\/IJMS23168972","journal-title":"Int J Mol Sci"},{"key":"6258_CR92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1871527316666170807130011\/CITE\/REFWORKS","volume":"18","author":"CJ Hwang","year":"2017","unstructured":"Hwang CJ, Choi D-Y, Park MH, Hong JT (2017) NF-\u03baB as a key mediator of brain inflammation in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 18:3\u201310. https:\/\/doi.org\/10.2174\/1871527316666170807130011\/CITE\/REFWORKS","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"6258_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-92","volume":"8","author":"M Song","year":"2011","unstructured":"Song M, Jin JJ, Lim JE et al (2011) TLR4 mutation reduces microglial activation, increases A\u03b2 deposits and exacerbates cognitive deficits in a mouse model of Alzheimer\u2019s disease. J Neuroinflammation 8(1):92. https:\/\/doi.org\/10.1186\/1742-2094-8-92","journal-title":"J Neuroinflammation"},{"key":"6258_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2020.00724\/FULL","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Wise L, Fukuchi KI (2020) TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer\u2019s disease. Front Immunol 11:526840. https:\/\/doi.org\/10.3389\/FIMMU.2020.00724\/FULL","journal-title":"Front Immunol"},{"key":"6258_CR95","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1097-2765(00)80244-0","volume":"5","author":"G Takaesu","year":"2000","unstructured":"Takaesu G, Kishida S, Hiyama A et al (2000) TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 5:649\u2013658. https:\/\/doi.org\/10.1016\/S1097-2765(00)80244-0","journal-title":"Mol Cell"},{"key":"6258_CR96","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/S12017-022-08726-X\/METRICS","volume":"25","author":"D Otgongerel","year":"2023","unstructured":"Otgongerel D, Lee HJ, Jo SA (2023) Induction of ICAM1 in brain vessels is implicated in an early AD pathogenesis by modulating neprilysin. Neuromolecular Med 25:193\u2013204. https:\/\/doi.org\/10.1007\/S12017-022-08726-X\/METRICS","journal-title":"Neuromolecular Med"},{"key":"6258_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12979-024-00445-0\/TABLES\/3","volume":"21","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Yang G, Luo Y et al (2024) Neuroinflammation in Alzheimer\u2019s disease: insights from peripheral immune cells. Immunity and Ageing 21:1\u201325. https:\/\/doi.org\/10.1186\/S12979-024-00445-0\/TABLES\/3","journal-title":"Immun Ageing"},{"key":"6258_CR98","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/JAD-240776","volume":"101","author":"OJ L\u2019Esperance","year":"2024","unstructured":"L\u2019Esperance OJ, McGhee J, Davidson G et al (2024) Functional connectivity favors aberrant visual network c-Fos expression accompanied by cortical synapse loss in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 101:111\u2013131. https:\/\/doi.org\/10.3233\/JAD-240776","journal-title":"J Alzheimers Dis"},{"key":"6258_CR99","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/J.CELREP.2017.06.040","volume":"20","author":"BF Corbett","year":"2017","unstructured":"Corbett BF, You JC, Zhang X et al (2017) \u0394FosB regulates gene expression and cognitive dysfunction in a mouse model of Alzheimer\u2019s disease. Cell Rep 20:344. https:\/\/doi.org\/10.1016\/J.CELREP.2017.06.040","journal-title":"Cell Rep"},{"issue":"6844","key":"6258_CR100","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/35085597","volume":"412","author":"C Wang","year":"2001","unstructured":"Wang C, Deng L, Hong M et al (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412(6844):346\u2013351. https:\/\/doi.org\/10.1038\/35085597","journal-title":"Nature"},{"key":"6258_CR101","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/S00011-006-6058-2","volume":"56","author":"C Orelio","year":"2007","unstructured":"Orelio C, Dzierzak E (2007) Expression analysis of the TAB2 protein in adult mouse tissues. Inflamm Res 56:98\u2013104. https:\/\/doi.org\/10.1007\/S00011-006-6058-2","journal-title":"Inflamm Res"},{"key":"6258_CR102","doi-asserted-by":"publisher","DOI":"10.1242\/JCS.260102","volume":"136","author":"K Sai","year":"2023","unstructured":"Sai K, Nakanishi A, Scofield KM et al (2023) Aberrantly activated TAK1 links neuroinflammation and neuronal loss in Alzheimer\u2019s disease mouse models. J Cell Sci 136:jcs260102. https:\/\/doi.org\/10.1242\/JCS.260102","journal-title":"J Cell Sci"},{"key":"6258_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41392-023-01486-5;SUBJMETA","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:1\u201332. https:\/\/doi.org\/10.1038\/S41392-023-01486-5;SUBJMETA","journal-title":"Signal Transduct Target Ther"},{"key":"6258_CR104","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/EURHEARTJ\/EHR304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33:829\u2013837. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHR304","journal-title":"Eur Heart J"},{"key":"6258_CR105","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/J.EURONEURO.2017.09.004","volume":"30","author":"HC Guti\u00e9rrez","year":"2020","unstructured":"Guti\u00e9rrez HC, O\u2019Leary A, Freudenberg F et al (2020) Nitric oxide interacts with monoamine oxidase to modulate aggression and anxiety-like behaviour. Eur Neuropsychopharmacol 30:30\u201343. https:\/\/doi.org\/10.1016\/J.EURONEURO.2017.09.004","journal-title":"Eur Neuropsychopharmacol"},{"key":"6258_CR106","doi-asserted-by":"publisher","unstructured":"Liu PL, Song AR, Dong CD et al (2021) Network pharmacology study on the mechanism of the herb pair of prepared Rehmannia root-Chinese arborvitae kernel for anxiety disorders. Ann Palliat Med 10:3313327. https:\/\/doi.org\/10.21037\/APM-21-531","DOI":"10.21037\/APM-21-531"},{"issue":"1","key":"6258_CR107","doi-asserted-by":"publisher","first-page":"13:13441","DOI":"10.1038\/s41598-023-39576-7","volume":"13","author":"R Manso-Calder\u00f3n","year":"2023","unstructured":"Manso-Calder\u00f3n R, Cacabelos-P\u00e9rez P, Sevillano-Garc\u00eda MD et al (2023) Analysis of endothelial gene polymorphisms in Spanish patients with vascular dementia and Alzheimer\u2019s disease. Sci Rep 13(1):13441. https:\/\/doi.org\/10.1038\/s41598-023-39576-7","journal-title":"Sci Rep"},{"key":"6258_CR108","unstructured":"Taylor G (2024) The interaction between nitric oxide synthase related short and long non-coding RNAs in the context of memory formation, aging and neurogenesis. Doctoral dissertation, University of Sussex. https:\/\/hdl.handle.net\/10779\/uos.25991041.v1. Accessed 3 Mar 2026"},{"key":"6258_CR109","unstructured":"National Center for Biotechnology Information (2024) HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 [Homo sapiens (human)]. NCBI Gene. https:\/\/www.ncbi.nlm.nih.gov\/gene\/3119. Accessed 3 Mar 2026"},{"key":"6258_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25052645","volume":"25","author":"E Angelopoulou","year":"2024","unstructured":"Angelopoulou E, Koros C, Hatzimanolis A et al (2024) Exploring the genetic landscape of mild behavioral impairment as an early marker of cognitive decline: an updated review focusing on Alzheimer\u2019s disease. Int J Mol Sci 25:2645. https:\/\/doi.org\/10.3390\/IJMS25052645","journal-title":"Int J Mol Sci"},{"key":"6258_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25158544","volume":"25","author":"CS C\u0103tan\u0103","year":"2024","unstructured":"C\u0103tan\u0103 CS, Marta MM, V\u0103leanu M et al (2024) Human leukocyte antigen and microRNAs as key orchestrators of mild cognitive impairment and Alzheimer\u2019s disease: a systematic review. Int J Mol Sci 25:8544. https:\/\/doi.org\/10.3390\/IJMS25158544","journal-title":"Int J Mol Sci"},{"key":"6258_CR112","doi-asserted-by":"publisher","unstructured":"Shigemizu D, Fukunaga K, Yamakawa A et al (2024) The HLA-DRB1*09:01-DQB1*03:03 haplotype is associated with the risk for late-onset Alzheimer\u2019s disease in APOE {{ }} 4\u2013negative Japanese adults. npj Aging 10(1):3. https:\/\/doi.org\/10.1038\/s41514-023-00131-3","DOI":"10.1038\/s41514-023-00131-3"},{"key":"6258_CR113","unstructured":"National Center for Biotechnology Information (2024) ATP1A2 ATPase Na+\/K+ transporting subunit alpha 2 [Homo sapiens (human)]. NCBI Gene. https:\/\/www.ncbi.nlm.nih.gov\/gene\/477. Accessed 3 Mar 2026"},{"key":"6258_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/1479-7364-7-8","volume":"7","author":"SM Gritz","year":"2013","unstructured":"Gritz SM, Radcliffe RA (2013) Genetic effects of ATP1A2 in familial hemiplegic migraine type II and animal models. Hum Genomics 7:8. https:\/\/doi.org\/10.1186\/1479-7364-7-8","journal-title":"Hum Genomics"},{"key":"6258_CR115","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/2211-5463.12848","volume":"10","author":"H Sugimoto","year":"2020","unstructured":"Sugimoto H, Sato M, Nakai J, Kawakami K (2020) Astrocytes in Atp1a2-deficient heterozygous mice exhibit hyperactivity after induction of cortical spreading depression. FEBS Open Bio 10:1031\u20131043. https:\/\/doi.org\/10.1002\/2211-5463.12848","journal-title":"FEBS Open Bio"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06258-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06258-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06258-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:06:29Z","timestamp":1791673589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06258-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6258"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06258-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"960"}}